Validation of the Spanish version of the Chronic Obstructive Pulmonary Disease-Population Screener (COPD-PS). Its usefulness and that of FEV 1/FEV6 for the diagnosis of COPD;Validación de la versión traducida del Chronic Obstructive Pulmonary Disease-Population Screener (COPD-PS). Su utilidad y la del FEV 1/FEV6 para el diagnóstico de enfermedad pulmonar obstructiva crónica

Medicina Clinica

Volumn 139, Issue 12, 2012, Pages 522-530

  Miravitlles, Marc ^a   Llor, Carles ^b   Calvo, Eduardo ^c   Diaz, Silvia ^d   Díaz Cuervo, Helena ^e   Gonzalez Rojas, Nuria ^f  

^a HOSPITAL CLÍNIC   (Spain)

^b Centro de Salud Jaume I   (Spain)

^c Centro de Salud Pozuelo i   (Spain)

^d PFIZER INC   (United States)

^e BAP Health Outcomes Oviedo ^*  (Spain)

^f SA Sant Cugat Del Vallés Barcelona   (Spain)

Author keywords

Chronic obstructive pulmonary disease; Forced expiratory volume in 6 seconds; Questionnaires; Screening

Indexed keywords

AIRWAY OBSTRUCTION; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CHRONIC OBSTRUCTIVE PULMONARY DISEASE POPULATION SCREENER; CONTROLLED STUDY; DIAGNOSTIC VALUE; EQ 5D; FEASIBILITY STUDY; FORCED EXPIRATORY VOLUME; FORCED EXPIRATORY VOLUME IN SIX SECONDS; GOLD STANDARD; HUMAN; MAJOR CLINICAL STUDY; MEDICAL DEVICE; OBSERVATIONAL STUDY; PREDICTIVE VALUE; PSYCHOMETRY; QUESTIONNAIRE; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; SPAIN; VALIDATION PROCESS; VALIDITY;

AGED; ALBUTEROL; AREA UNDER CURVE; BRONCHODILATOR AGENTS; CROSS-SECTIONAL STUDIES; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PSYCHOMETRICS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUESTIONNAIRES; REPRODUCIBILITY OF RESULTS; SAMPLING STUDIES; SENSITIVITY AND SPECIFICITY; SOCIOECONOMIC FACTORS; SPAIN; TRANSLATING;

EID: 84867842042     PISSN: 00257753     EISSN: 15788989     Source Type: Journal    
DOI: 10.1016/j.medcli.2011.06.022     Document Type: Article

References (32)

1. J.B. Soriano, J. Zielinski, and D. Price Screening for and early detection of chronic obstructive pulmonary disease Lancet 374 2009 721 732
2. M. Miravitlles, J.B. Soriano, F. Garcia-Rio, L. Munoz, E. Duran-Tauleria, and G. Sanchez Prevalence of COPD in Spain: impact of undiagnosed COPD on quality of life and daily life activities Thorax 64 2009 863 868
3. C.P. Van Schayck, R.J. Halbert, R.J. Nordyke, S. Isonaka, J. Maroni, and D. Nonikov Comparison of existing symptom-based questionnaires for identifying COPD in the general practice setting Respirology 10 2005 323 333
4. F.J. Martinez, A.E. Raczek, F.D. Seifer, C.S. Conoscenti, T.G. Curtice, and T. D'Eletto Development and initial validation of a self-scored COPD Population Screener Questionnaire (COPD-PS) COPD 5 2008 85 95
5. E. Derom, C. van Weel, G. Liistro, J. Buffels, T. Schermer, and E. Lammers Primary care spirometry Eur Respir J 31 2008 197 203
6. C. Represas Represas, M. Botana Rial, V. Leiro Fernández, A.I. González Silva, V. del Campo Pérez, and A. Fernandez-Villar Validación del dispositivo portátil COPD-6 para la detección de patologías obstructivas de la vía aérea Arch Bronconeumol 46 2010 426 432
7. J.Y. Jing, T.C. Huang, W. Cui, F. Xu, and H.H. Shen Should FEV1/FEV6 replace FEV1/FVC ratio to detect airway obstruction? A metaanalysis Chest 135 2009 991 998
8. J. Sanchis Aldás, P. Casan Clarà, J. Castillo Gómez, N. González Mangado, L. Palenciano Ballesteros, and J. Roca Torrent Normativa para la práctica de la espirometría forzada Arch Bronconeumol 25 1989 132 142
9. EuroQol- a new facility for the measurement of health-related quality of life. The EuroQol Group. Health Policy 1990;16:199-208.
10. X. Badia, M. Roset, S. Monserrat, M. Herdman, and A. Segura La versión española del EuroQoL: descripción y aplicaciones Med Clin (Barc) 112 1999 79 86
11. A.S. Pickard, C. Wilke, E. Jung, S. Patel, K. Stavem, and T.A. Lee Use of a preference-based measure of health (EQ-5D) in COPD and asthma Respir Med 102 2008 519 536
12. D. Freeman, R.J. Nordyke, S. Isonaka, D.V. Nonikov, J.M. Maroni, and D. Price Questions for COPD diagnostic screening in a primary care setting Respir Med 99 2005 1311 1318
13. J. Vilaró, E. Gimeno, N. Sánchez Férez, C. Hernando, I. Díaz, and M. Ferrer Actividades de la vida diaria en pacientes con enfermedad pulmonar obstructiva crónica: validación de la traducción española y análisis comparativo de 2 cuestionarios Med Clin (Barc) 129 2007 326 332
14. D.B. Price, D.G. Tinkelman, R.J. Halbert, R.J. Nordyke, S. Isonaka, and D. Nonikov Symptom-based questionnaire for identifying COPD in smokers Respiration 73 2006 285 295
15. D.B. Price, D.G. Tinkelman, R.J. Nordyke, S. Isonaka, and R.J. Halbert Scoring system and clinical application of COPD diagnostic questionnaires Chest 129 2006 1531 1539
16. D. Kotz, P. Nelemans, C.P. van Schayck, and G.J. Wesseling External validation of a COPD diagnostic questionnaire Eur Respir J 31 2008 298 303
17. K. Kida, R. Wakabayashi, T. Mizuuchi, and A. Murata Screening for suspected chronic obstructive pulmonary disease with an eleven-item pre-interview questionnaire (11-Q) Intern Med 45 2006 1201 1207
18. H. Mullerova, J. Wedzicha, J.B. Soriano, and J. Vestbo Validation of a chronic obstructive pulmonary disease screening questionnaire for population surveys Respir Med 98 2004 78 83
19. B.P. Yawn, D.W. Mapel, D.M. Mannino, F.J. Martinez, J.F. Donohue, and N.A. Hanania Development of the Lung Function Questionnaire (LFQ) to identify airflow obstruction Int J Chron Obst Pulm Dis 5 2010 1 10
20. M. Miravitlles, I. Fernandez, T. Guerrero, and C. Murio Desarrollo y resultados de un programa de cribado de la EPOC en Atención Primaria. El proyecto PADOC Arch Bronconeumol 36 2000 500 505
21. J. Zielinski, and M. Bednarek Early detection of COPD in a high-risk population using spirometric screening Chest 119 2001 731 736
22. P.P. Walker, P. Mitchell, F. Diamantea, C.J. Warburton, and L. Davies Effects of primary-care spirometry on the diagnosis and management of COPD Eur Respir J 28 2006 945 952
23. K. Naberan, C. de la Roza, M. Lamban, E. Gobartt, A. Martín, and M. Miravitlles Use of spirometry in the diagnosis and treatment of chronic obstructive pulmonary disease in Primary Care Arch Bronconeumol 42 2006 638 644
24. T.R. Schermer, J.E. Jacobs, N.H. Chavannes, J. Hartman, H.T. Folgering, and B.J. Bottema Validity of spirometric testing in a general practice population of patients with chronic obstructive pulmonary disease (COPD) Thorax 58 2003 861 866
25. M. Lusuardi, F. De Benedetto, P. Paggiaro, C.M. Sanguinetti, G. Brazzola, and P. Ferri A randomized controlled trial on office spirometry in asthma and COPD in standard general practice: data from spirometry in Asthma and COPD: a comparative evaluation Italian study Chest 129 2006 844 852
26. F.W. Rosa, R. Perez-Padilla, A. Camelier, O.A. Nascimento, A.M. Menezes, and J.R. Jardim Efficacy of the FEV1/FEV6 ratio compared to the FEV1/FVC ratio for the diagnosis of airway obstruction in subjects aged 40 years or over Braz J Med Biol Res 40 2007 1615 1621
27. J. Vandevoorde, S. Verbanck, D. Schuermans, J. Kartounian, and W. Vincken FEV1/FEV6 and FEV6 as an alternative for FEV1/FVC and FVC in the spirometric detection of airway obstruction and restriction Chest 127 2005 1560 1564
28. M. Kaufmann, S. Hartl, K. Geyer, M.K. Breyer, and O.C. Burghuber Measuring FEV6 for detecting early airway obstruction in the primary care setting Respiration 78 2009 161 167
29. R. De Marco What evidence could validate the definition of COPD? Thorax 63 2008 756 757
30. J. Clotet, X. Gómez-Arbonés, C. Ciria, and J.M. Albalad La espirometría es un buen método para la detección y el seguimiento de la EPOC en fumadores de alto riesgo en atención primaria Arch Bronconeumol 40 2004 155 159
31. V.R. Cabedo García, C.R. Garcés Asemany, A. Cortes Berti, J.T. Oteo Elso, and F.J. Ballester Salvador Eficacia de la utilización correcta de los dispositivos de inhalación en pacientes con enfermedad pulmonar obstructiva crónica: ensayo clinico aleatorizado Med Clin (Barc) 135 2010 586 591
32. M. Decramer, M. Miravitlles, D. Price, M. Román-Rodríguez, C. Llor, and T. Welte New horizons in early stage COPD-Improving knowledge, detection and treatment Respir Med 105 2011 1576 1587